| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000020803 |
| Receipt No. | R000024015 |
| Scientific Title | A method comparison study of FeNO measurements, between the NOA280i and the NIOX VERO |
| Date of disclosure of the study information | 2016/02/01 |
| Last modified on | 2019/08/02 (Ver. 10) |
| Basic information | ||
| Public title | A method comparison study of FeNO measurements, between the NOA280i and the NIOX VERO | |
| Acronym | A method comparison study of FeNO measurements, between the NOA280i and the NIOX VERO | |
| Scientific Title | A method comparison study of FeNO measurements, between the NOA280i and the NIOX VERO | |
| Scientific Title:Acronym | A method comparison study of FeNO measurements, between the NOA280i and the NIOX VERO | |
| Region |
|
|
| Condition | ||||
| Condition | asthma | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | To investigate whether FeNO values obtained with the NIOX VERO are comparable with the NOA280i. |
| Basic objectives2 | Bio-equivalence |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Coefficient calculated for FeNO values obtained with the NOA280i and the NIOX VERO |
| Key secondary outcomes | Bland-Altman plot used to assess agreement between FeNO values obtained with the NOA280i and the NIOX VERO |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | FeNO values are measured in all participants, using both the NIOX VERO and the NOA280i.
Three acceptable measurement is performed with each device. |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Asthmatic patients who give written informed consent to this study. | |||
| Key exclusion criteria | Those who need oxygenation.
Those who can not perform technically adequate measurements. |
|||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Shizuoka General Hospital | ||||||
| Division name | Pneumology | ||||||
| Zip code | 420-8527 | ||||||
| Address | 4-27-1 Kita-ando, Shizuoka city, Shizuoka, Japan | ||||||
| TEL | 054-247-6111 | ||||||
| taisuke-akamatsu@i.shizuoka-pho.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Shizuoka General Hospital | ||||||
| Division name | Pneumology | ||||||
| Zip code | 420-8527 | ||||||
| Address | 4-27-1 Kita-ando, Shizuoka city, Shizuoka, Japan | ||||||
| TEL | 054-247-6111 | ||||||
| Homepage URL | |||||||
| taisuke-akamatsu@i.shizuoka-pho.jp | |||||||
| Sponsor | |
| Institute | Shizuoka General Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Shizuoka General Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Clinical Research Ethics Committee, Shizuoka General Hospital |
| Address | 4-27-1 Kita Ando Aoi-ku, Shizuoka City Japan |
| Tel | 054-247-6111 |
| chiken-sougou@shizuoka-pho.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 静岡県立総合病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | https://www.clinicalkey.jp/#!/content/playContent/1-s2.0-S1081120617305938?returnurl=https:%2F%2Flin |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | https://www.clinicalkey.jp/#!/content/playContent/1-s2.0-S1081120617305938?returnurl=https:%2F%2Flin | ||||||
| Number of participants that the trial has enrolled | 107 | ||||||
| Results | FeNO levels measured using the NIOX VERO (mean +- SD 53.4 +- 38.9 ppb) were significantly higher than those using the NOA 280i (41.7 +- 33.2 ppb; P < .0001). However, there was a significant correlation between FeNO levels measured with the two devices (r = 0.946, P < .0001). The Bland-Altman plot showed a moderate degree of agreement between the 2 devices; the mean inter-device difference was 11.7 ppb (95% limits of agreement -13.5 and 37.0 ppb). |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | Subjects included 107 adult patients with bronchial asthma (51 men and 56 women; 59 nonsmokers, 46 ex-smokers, and 2 current smokers; 75 with and 32 without atopy; mean age 60 years, mean body mass index 24.0 kg/m 2 , and mean predicted percentage of forced expiratory volume in 1 second 82.6%). |
||||||
| Participant flow | There were no excluded patients. |
||||||
| Adverse events | No troubles. |
||||||
| Outcome measures | - Coefficient calculated for FeNO values obtained with the NOA280i and the NIOX VERO - Bland-Altman plot used to assess agreement between FeNO values obtained with the NOA280i and the NIOX VERO (See Results) |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024015 |